This weekend, while speaking at the Liberty Forum of Silicon Valley, I was asked a question about the status of the development of an influenza/COVID-19 mRNA vaccine.A quick search on clinicaltrials.gov (which is a government website where clinical trials are registered), found the following combined influenza/COVID-19 clinical trial, which is currently recruiting:A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years OldThis is a phase 1 and 2 combined randomized clinical trial which anticipates enrollment of 1,050 participants.Today, a reader sent me a link to the article below, which clearly shows that the pre-clinical...